Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-01-28 Purchase |
2022-01-31 08:41 am |
Onconova Therapeutics Inc. | ONTX | OLER ABRAHAM N. SVP Corp Dev & Gen Counsel |
1,500 | $1.67 | $2,505 | 24,514 (Direct) |
View |
| 2022-01-21 Purchase |
2022-01-24 08:40 am |
Onconova Therapeutics Inc. | ONTX | OLER ABRAHAM N. SVP Corp Dev & Gen Counsel |
1,500 | $2.02 | $3,030 | 23,014 (Direct) |
View |
| 2022-01-14 Purchase |
2022-01-18 09:12 am |
Onconova Therapeutics Inc. | ONTX | OLER ABRAHAM N. SVP CORP DEV & GEN COUNSEL |
1,500 | $2.2 | $3,300 | 21,514 (Direct) |
View |
| 2022-01-07 Purchase |
2022-01-10 08:39 am |
Onconova Therapeutics Inc. | ONTX | OLER ABRAHAM N. SVP Corp Dev & Gen Counsel |
1,500 | $2.39 | $3,585 | 20,014 (Direct) |
View |
| 2021-11-19 Purchase |
2021-11-23 09:20 am |
Onconova Therapeutics Inc. | ONTX | OLER ABRAHAM N. SVP CORP DEV & GEN COUNSEL |
1,000 | $3.16 | $3,160 | 18,514 (Direct) |
View |
| 2021-09-28 Purchase |
2021-09-29 08:27 am |
Onconova Therapeutics Inc. | ONTX | OLER ABRAHAM N. SVP Corp Dev & Gen Counsel |
2,381 | $4.2 | $10,000 | 12,515 (Direct) |
View |
| 2021-09-28 Purchase |
2021-09-29 08:25 am |
Onconova Therapeutics Inc. | ONTX | Gelder Mark S. MD Chief Medical Officer |
2,381 | $4.2 | $10,000 | 2,381 (Direct) |
View |
| 2021-09-28 Purchase |
2021-09-28 12:34 pm |
Onconova Therapeutics Inc. | ONTX | Fruchtman Steven M President, Chief Executive Off |
2,381 | $4.2 | $10,000 | 18,130 (Direct) |
View |
| 2021-09-28 Purchase |
2021-09-28 12:32 pm |
Onconova Therapeutics Inc. | ONTX | MARINO JAMES J Director |
5,952 | $4.2 | $24,998 | 21,334 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-08-10 Option Award |
2023-08-14 5:43 pm |
2024-08-10 2033-08-10 |
Onconova Therapeutics Inc. | ONTX | GROOPMAN JEROME Director |
66,468 | $0 | 66,468 (Direct) |
View |
| 2023-08-10 Option Award |
2023-08-14 5:41 pm |
2024-08-10 2033-08-10 |
Onconova Therapeutics Inc. | ONTX | MARINO JAMES J Director |
66,468 | $0 | 66,468 (Direct) |
View |
| 2023-08-02 Exercise |
2023-08-04 4:45 pm |
N/A N/A |
Onconova Therapeutics Inc. | ONTX | Guerin Mark Patrick CFO AND COO |
4,750 | $0 | 30,194 (Direct) |
View |
| 2023-08-03 Tax Withholding |
2023-08-04 4:45 pm |
N/A N/A |
Onconova Therapeutics Inc. | ONTX | Guerin Mark Patrick CFO AND COO |
1,422 | $1.02 | 30,194 (Direct) |
View |
| 2023-08-02 Exercise |
2023-08-04 4:42 pm |
N/A N/A |
Onconova Therapeutics Inc. | ONTX | Fruchtman Steven M PRESIDENT, CHIEF EXECUTIVE OFF |
12,567 | $0 | 60,867 (Direct) |
View |
| 2023-08-03 Tax Withholding |
2023-08-04 4:42 pm |
N/A N/A |
Onconova Therapeutics Inc. | ONTX | Fruchtman Steven M PRESIDENT, CHIEF EXECUTIVE OFF |
4,744 | $1.01 | 60,867 (Direct) |
View |
| 2023-06-12 Exercise |
2023-06-13 4:54 pm |
N/A N/A |
Onconova Therapeutics Inc. | ONTX | Guerin Mark Patrick CFO AND COO |
5,500 | $0 | 33,116 (Direct) |
View |
| 2023-06-12 Tax Withholding |
2023-06-13 4:54 pm |
N/A N/A |
Onconova Therapeutics Inc. | ONTX | Guerin Mark Patrick CFO AND COO |
1,575 | $1.137 | 33,116 (Direct) |
View |
| 2023-03-13 Option Award |
2023-03-14 7:19 pm |
N/A 2033-03-13 |
Onconova Therapeutics Inc. | ONTX | Guerin Mark Patrick CFO AND COO |
105,000 | $0 | 105,000 (Direct) |
View |
| 2023-03-13 Option Award |
2023-03-14 6:48 pm |
N/A 2033-03-13 |
Onconova Therapeutics Inc. | ONTX | Fruchtman Steven M PRESIDENT, CHIEF EXECUTIVE OFF |
276,333 | $0 | 276,333 (Direct) |
View |
| 2023-03-13 Option Award |
2023-03-14 6:46 pm |
N/A 2033-03-13 |
Onconova Therapeutics Inc. | ONTX | Gelder Mark S. MD CHIEF MEDICAL OFFICER |
82,667 | $0 | 82,667 (Direct) |
View |
| 2023-02-07 Exercise |
2023-02-08 6:00 pm |
N/A N/A |
Onconova Therapeutics Inc. | ONTX | Fruchtman Steven M PRESIDENT, CHIEF EXECUTIVE OFF |
21,320 | $0 | 83,117 (Direct) |
View |
| 2023-02-07 Tax Withholding |
2023-02-08 6:00 pm |
N/A N/A |
Onconova Therapeutics Inc. | ONTX | Fruchtman Steven M PRESIDENT, CHIEF EXECUTIVE OFF |
6,977 | $1.36 | 83,117 (Direct) |
View |
| 2023-02-07 Exercise |
2023-02-08 5:58 pm |
N/A N/A |
Onconova Therapeutics Inc. | ONTX | Gelder Mark S. MD CHIEF MEDICAL OFFICER |
5,833 | $0 | 22,154 (Direct) |
View |
| 2023-02-07 Tax Withholding |
2023-02-08 5:58 pm |
N/A N/A |
Onconova Therapeutics Inc. | ONTX | Gelder Mark S. MD CHIEF MEDICAL OFFICER |
1,242 | $1.36 | 22,154 (Direct) |
View |
| 2023-02-07 Exercise |
2023-02-08 5:56 pm |
N/A N/A |
Onconova Therapeutics Inc. | ONTX | Guerin Mark Patrick CFO AND COO |
6,900 | $0 | 31,991 (Direct) |
View |
| 2023-02-07 Tax Withholding |
2023-02-08 5:56 pm |
N/A N/A |
Onconova Therapeutics Inc. | ONTX | Guerin Mark Patrick CFO AND COO |
1,785 | $1.36 | 31,991 (Direct) |
View |
| 2022-12-15 Option Award |
2022-12-19 6:59 pm |
N/A 2032-12-15 |
Onconova Therapeutics Inc. | ONTX | Clarke Trafford Director |
100,000 | $0 | 100,000 (Direct) |
View |
| 2022-12-15 Option Award |
2022-12-19 6:56 pm |
N/A 2032-12-15 |
Onconova Therapeutics Inc. | ONTX | Atadja Peter Director |
100,000 | $0 | 100,000 (Direct) |
View |
| 2022-08-18 Option Award |
2022-08-19 5:10 pm |
2023-08-18 2032-08-18 |
Onconova Therapeutics Inc. | ONTX | STOVER JACK E Director |
66,468 | $0 | 66,468 (Direct) |
View |
| 2022-08-18 Option Award |
2022-08-19 4:59 pm |
2023-08-18 2032-08-18 |
Onconova Therapeutics Inc. | ONTX | MARINO JAMES J Director |
66,468 | $0 | 66,468 (Direct) |
View |
| 2022-08-18 Option Award |
2022-08-19 4:57 pm |
2023-08-18 2032-08-18 |
Onconova Therapeutics Inc. | ONTX | MEHTA VIREN Director |
66,468 | $0 | 66,468 (Direct) |
View |
| 2022-08-18 Option Award |
2022-08-19 4:55 pm |
2023-08-18 2032-08-18 |
Onconova Therapeutics Inc. | ONTX | Shoemaker Mary Teresa Director |
66,468 | $0 | 66,468 (Direct) |
View |
| 2022-08-18 Option Award |
2022-08-19 4:54 pm |
2023-08-18 2032-08-18 |
Onconova Therapeutics Inc. | ONTX | GROOPMAN JEROME Director |
66,468 | $0 | 66,468 (Direct) |
View |
| 2022-08-02 Exercise |
2022-08-04 4:38 pm |
N/A N/A |
Onconova Therapeutics Inc. | ONTX | Guerin Mark Patrick CFO AND COO |
4,750 | $0 | 22,576 (Direct) |
View |
| 2022-08-03 Tax Withholding |
2022-08-04 4:38 pm |
N/A N/A |
Onconova Therapeutics Inc. | ONTX | Guerin Mark Patrick CFO AND COO |
1,355 | $1.32 | 22,576 (Direct) |
View |
| 2022-08-02 Exercise |
2022-08-04 4:34 pm |
N/A N/A |
Onconova Therapeutics Inc. | ONTX | Gelder Mark S. MD CHIEF MEDICAL OFFICER |
4,650 | $0 | 15,196 (Direct) |
View |
| 2022-08-03 Tax Withholding |
2022-08-04 4:34 pm |
N/A N/A |
Onconova Therapeutics Inc. | ONTX | Gelder Mark S. MD CHIEF MEDICAL OFFICER |
1,135 | $1.32 | 15,196 (Direct) |
View |
| 2022-08-02 Exercise |
2022-08-04 4:30 pm |
N/A N/A |
Onconova Therapeutics Inc. | ONTX | Fruchtman Steven M PRESIDENT, CHIEF EXECUTIVE OFF |
12,566 | $0 | 51,268 (Direct) |
View |
| 2022-08-03 Tax Withholding |
2022-08-04 4:30 pm |
N/A N/A |
Onconova Therapeutics Inc. | ONTX | Fruchtman Steven M PRESIDENT, CHIEF EXECUTIVE OFF |
4,562 | $1.32 | 51,268 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-13 4:03 pm |
N/A 2032-06-10 |
Onconova Therapeutics Inc. | ONTX | Guerin Mark Patrick COO and CFO |
66,750 | $0 | 66,750 (Direct) |
View |
| 2022-02-07 Option Award |
2022-02-09 4:52 pm |
N/A 2032-02-07 |
Onconova Therapeutics Inc. | ONTX | Gelder Mark S. MD Chief Medical Officer |
69,250 | $0 | 69,250 (Direct) |
View |
| 2022-02-07 Option Award |
2022-02-09 4:41 pm |
N/A 2032-02-07 |
Onconova Therapeutics Inc. | ONTX | Fruchtman Steven M President, Chief Executive Off |
255,840 | $0 | 255,840 (Direct) |
View |
| 2022-02-07 Option Award |
2022-02-09 4:38 pm |
N/A 2032-02-07 |
Onconova Therapeutics Inc. | ONTX | OLER ABRAHAM N. SVP Corp Dev & Gen Counsel |
71,683 | $0 | 71,683 (Direct) |
View |
| 2022-02-07 Option Award |
2022-02-09 4:33 pm |
N/A 2032-02-07 |
Onconova Therapeutics Inc. | ONTX | Guerin Mark Patrick Chief Financial Officer |
82,800 | $0 | 82,800 (Direct) |
View |
| 2021-11-18 Exercise |
2021-11-19 08:45 am |
2019-11-25 2024-11-25 |
Onconova Therapeutics Inc. | ONTX | OLER ABRAHAM N. SVP Corp Dev & Gen Counsel |
5,000 | $0 | 17,514 (Direct) |
View |
| 2021-11-18 Exercise |
2021-11-19 08:45 am |
N/A N/A |
Onconova Therapeutics Inc. | ONTX | OLER ABRAHAM N. SVP Corp Dev & Gen Counsel |
5,000 | $3 | 17,514 (Direct) |
View |
| 2021-08-02 Option Award |
2021-08-04 8:04 pm |
N/A 2031-08-02 |
Onconova Therapeutics Inc. | ONTX | Fruchtman Steven M President, Chief Executive Off |
150,700 | $0 | 150,700 (Direct) |
View |
| 2021-08-02 Option Award |
2021-08-04 8:02 pm |
N/A 2031-08-02 |
Onconova Therapeutics Inc. | ONTX | Gelder Mark S. MD Chief Medical Officer |
55,775 | $0 | 55,775 (Direct) |
View |